1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Women’s Health - 5EU Analysis and Market Forecasts

Women’s Health - 5EU Analysis and Market Forecasts

Summary

The Women’s Health medical devices market encompasses treatments for conditions that are particular to the adult female anatomy. This includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, as well as pelvic disorders such as female stress urinary incontinence. Moreover, there is a sub-segment of the female population that no longer desire to become pregnant, and seek permanent solutions to avoid conception.

In recent years, minimally invasive techniques and technologies have been developed to treat these conditions as alternatives to conventional surgery; these technologies are expected to see increased adoption in the coming years due to increased physician and patient awareness as well as an increasing number of women who are proactively seeking treatment for these embarrassing, and sometimes debilitating, conditions. However, recent lawsuits related to safety issues with some of these devices that are receiving widespread media attention, particularly in the urinary incontinence sling market, have caused some women to be skeptical of these newer technologies.

The technologies covered in this report include global endometrial devices, endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. The women’s health market is determined for the five major European markets (5EU): France, Germany, Italy, Spain, and the UK. The report provides insights into the competitive landscape, the marketed and pipeline products, the current and emerging players and market analysis of the different device segments within the women’s health market in the 5EU. The report also provides insight into the unmet needs and an understanding of physician perceptions of the market. This report is built using data and information sourced from secondary sources and primary research interviews with leading gynecologists, urogynecologists, interventional radiologists, and general surgeons, with in-house analysis conducted by GlobalData’s team of industry experts.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Questions Answered

- What is the current and future women’s health market outlook in the 5EU? What trends are affecting these markets?
- Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with women’s health devices currently on the market? How will emerging technologies fulfill these unmet needs?
- What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for women’s health devices?
- What are the challenges and complications that have hindered widespread adoption of newer technologies?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the 5EU women’s health market?

Scope

- Overview of women’s health, including anatomy, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
- Annualized total women’s health market revenue from 2011-2021 including adoption patterns in the 5EU.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, and implications for the women’s health market.
- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and women’s health devices in development.
- Analysis of the current and future market competition in the 5EU women’s health market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading gynecologists, urogynecologists, interventional radiologists, and general surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table Of Contents

Women’s Health - 5EU Analysis and Market Forecasts
1 Table of Contents
1.1 List of Figures
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 Overview
3.1.1 Anatomy
3.2 Indications
3.2.1 Overview
3.2.2 Abnormal Uterine Conditions
3.2.3 Female Urinary Incontinence
3.3 Clinical Presentation
3.3.1 Abnormal Uterine Conditions
3.3.2 Female Urinary Incontinence
3.4 Market Segmentation
3.5 Market Access
3.5.1 Purchasing Decisions
3.6 Influence of Clinical Trials
3.7 Adoption
3.8 Regulation
3.8.1 5EU
3.9 Reimbursement
3.9.1 5EU
3.10 Procedure Trends
3.10.1 By Region
3.11 Regulatory Issues/Recalls
3.11.1 Hologic Discontinues Manufacturing, Marketing, and Sales of Adiana
3.11.2 Recall of Numerous Transvaginal Mesh Products
3.12 MandAs, Key Partnerships
3.12.1 Bayer Health Acquires Conceptus for $1.1 Billion
3.12.2 Boston Scientific Acquires IoGyn for $65m
3.13 Economic Impact
3.13.1 Indirect Costs
3.13.2 Direct Costs
4 Unmet Needs
4.1 Overview
4.2 Endometrial Ablation/Resection Devices
4.2.1 Better Fluid Management
4.2.2 Improved Imaging Guidance
4.2.3 Regulating Depth of Ablation
4.3 Uterine Fibroid Embolization Agents
4.3.1 Addressing Fibroid Recurrence
4.3.2 Assessing Effect on Fertility
4.3.3 Preventing Ovarian Failure
4.4 Female Sterilization Devices
4.4.1 Accelerated Scar Tissue Formation
4.4.2 Lack of Reversibility
4.4.3 Preventing Micro-insert Migration
4.4.4 Preventing Perforation
4.4.5 Trocar Size Reduction
4.5 Female Urinary Incontinence Slings
4.5.1 Anatomical Adaptation
4.5.2 Single-Incision Slings
5 Market Opportunity Analysis
5.1 Overview
5.2 Endometrial Ablation/Resection Devices
5.2.1 Targeted Fibroid Ablation
5.3 Uterine Fibroid Embolization Agents
5.3.1 Novel Agents
5.4 Female Sterilization Devices
5.4.1 Raising Patient Awareness
5.4.2 Rapid Transcervical Sterilization
5.5 Female Urinary Incontinence Slings
5.5.1 Materials and Coatings
5.5.2 European and APAC Markets
6 Market Drivers and Barriers
6.1 Endometrial Ablation/Resection
6.1.1 Driver: Patient Preference for Minimally Invasive Treatments
6.1.2 Driver: Growing Procedure Volume
6.1.3 Barrier: High Device and Procedure Cost
6.1.4 Substitute: Hysterectomy
6.1.5 Substitute: Intrauterine Devices
6.2 Uterine Fibroid Embolization Agents
6.2.1 Driver: Increasing Prevalence of Uterine Fibroids
6.2.2 Driver: Improving Imaging Capabilities
6.2.3 Barrier: Lack of Patient Awareness
6.2.4 Substitute: MRI-guided Focused Ultrasound
6.2.5 Substitute: Myomectomy
6.3 Female Sterilization Devices
6.3.1 Driver: Growing Female Population using Modern Contraception
6.3.2 Driver: Increasing Adoption of Transcervical Sterilization
6.3.3 Barrier: Patient Preference for Reversible Contraception
6.3.4 Substitute: Traditional Contraception
6.4 Female Urinary Incontinence Slings
6.4.1 Driver: Growing Treatment Rates and Use of Surgery
6.4.2 Barrier: Highly Litigious US Market
6.4.3 Substitute: Surgical Repair
6.4.4 Substitute: Pelvic Floor Electrical Stimulation
7 Competitive Assessment
7.1 Overview
7.2 Classification Based on Features
7.2.1 Endometrial Ablation Devices
7.2.2 Endometrial Resection Devices
7.2.3 Uterine Fibroid Embolization Agents
7.2.4 Female Sterilization Devices
7.2.5 Female Urinary Incontinence Slings
7.3 Key Product Profiles
7.3.1 Endometrial Ablation Devices
7.3.2 Endometrial Resection Devices
7.3.3 Uterine Fibroid Embolization Agents
7.3.4 Female Sterilization Devices
7.3.5 Female Urinary Incontinence Slings
8 Pipeline Assessment
8.1 Overview
8.2 Key Product Profiles
8.2.1 Endometrial Ablation Devices
8.2.2 Uterine Fibroid Embolization Agents
8.2.3 Female Sterilization Devices
8.2.4 Female Urinary Incontinence Slings
9 Clinical Trials to Watch
9.1 Overview
9.2 Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
9.3 Post Market Study of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx)
9.4 Safety and Effectiveness Study of Aegea Vapor System to Treat Excessive Uterine Bleeding
9.5 The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY)
10 Current and Future Players
10.1 Overview
10.2 Trends in Corporate Strategy
10.3 Company Profiles
10.3.1 American Medical Systems
10.3.2 AngioDynamics
10.3.3 Bayer Healthcare (Bayer AG)
10.3.4 Boston Scientific
10.3.5 BTG
10.3.6 Coloplast
10.3.7 Cook Medical
10.3.8 CooperSurgical
10.3.9 C.R. Bard
10.3.10 Ethicon (Johnson and Johnson)
10.3.11 Femcare-Nikomed (Utah Medical Products)
10.3.12 Hologic
10.3.13 Karl Storz
10.3.14 Olympus
10.3.15 Richard Wolf
10.3.16 Stryker
11 Market Outlook
11.1 By Geography
11.1.1 By Region
11.1.2 By Country
12 Appendix
12.1 Bibliography
12.2 Abbreviations
12.3 Report Methodology
12.3.1 Overview
12.3.2 Coverage
12.3.3 Secondary Research
12.4 Forecasting Methodology
12.5 Physicians and Specialists Included in This Study
12.6 Primary Research - Prescriber Survey
12.7 About the Authors
12.7.1 Analysts
12.7.2 Global Head of Healthcare
12.8 About GlobalData
12.9 Disclaimer

1.1 List of Figures
Table 1: Types of Uterine Fibroids
Table 2: Types of Female Urinary Incontinence
Table 3: Drug and Hormone Treatments for Menorrhagia
Table 4: Surgical Treatments for Menorrhagia
Table 5: Treatments for Stress, Urge, and Mixed Urinary Incontinence
Table 6: Market Segmentation for Women's Health Market
Table 7: Regulatory Differences Between the US and EU for the Approval of Medical Devices
Table 8: Endometrial Ablation Devices, SWOT Analysis, 2015
Table 9: Currently Marketed Endometrial Ablation Devices, 2015
Table 10: Endometrial Resection, SWOT Analysis, 2015
Table 11: Uterine Fibroid Embolization, SWOT Analysis, 2015
Table 12: Device-based Permanent Female Sterilization, SWOT Analysis, 2015
Table 13: Currently Marketed Notable Female Urinary Incontinence Slings, 2015
Table 14: Female Urinary Incontinence Slings, SWOT Analysis, 2015
Table 15: Product Profile - Cavaterm (Veldana Medical)
Table 16: Cavaterm, SWOT Analysis, 2015
Table 17: Product Profile - ThermaChoice (Ethicon)
Table 18: ThermaChoice, SWOT Analysis, 2015
Table 19: Product Profile - Genesys HTA (Boston Scientific)
Table 20: Genesys HTA, SWOT Analysis, 2015
Table 21: Product Profile - NovaSure (Hologic)
Table 22: NovaSure, SWOT Analysis, 2015
Table 23: Product Profile - Minerva Endometrial Ablation System (Minerva Surgical)
Table 24: Minerva Endometrial Ablation System, SWOT Analysis, 2015
Table 25: Product Profile - Her Option (CooperSurgical)
Table 26: Her Option, SWOT Analysis, 2015
Table 27: Product Profile - Acculis MTA (AngioDynamics)
Table 28: Acculis MTA, SWOT Analysis, 2015
Table 29: Product Profile - Acessa (Halt Medical)
Table 30: Acessa, SWOT Analysis, 2015
Table 31: Product Profile - Sonata (Gynesonics)
Table 32: Sonata, SWOT Analysis, 2015
Table 33: Product Profile - 26Fr Continuous Flow Resectoscope (Stryker)
Table 34: 26Fr Continuous Flow Resectoscope, SWOT Analysis, 2015
Table 35: Product Profile - Karl Storz Bipolar Resectoscope (Karl Storz)
Table 36: Karl Storz Bipolar Resectoscope, SWOT Analysis, 2015
Table 37: Product Profile - SurgMaster Resectoscope (Olympus)
Table 38: SurgMaster Resectoscope, SWOT Analysis, 2015
Table 39: Product Profile - Princess Resectoscope (Richard Wolf)
Table 40: Princess Resectoscope, SWOT Analysis, 2015
Table 41: Product Profile - Versapoint (Ethicon)
Table 42: Versapoint, SWOT Analysis, 2015
Table 43: Product Profile - Gelfoam (Pfizer)
Table 44: Gelfoam, SWOT Analysis, 2015
Table 45: Product Profile - Bead Block (BTG)
Table 46: Bead Block, SWOT Analysis, 2015
Table 47: Product Profile - Contour PVA Embolization Particles (Boston Scientific)
Table 48: Contour PVA Embolization Particles, SWOT Analysis, 2015
Table 49: Product Profile - PVA Foam Embolization Particles (Cook Medical)
Table 50: PVA Foam Embolization Particles, SWOT Analysis, 2015
Table 51: Product Profile - Embosphere Microspheres (Merit Medical Systems)
Table 52: Embosphere Microspheres, SWOT Analysis, 2015
Table 53: Product Profile - Filshie Clip (Femcare-Nikomed)
Table 54: Filshie Clip, SWOT Analysis, 2015
Table 55: Product Profile - Essure (Bayer Healthcare)
Table 56: Essure, SWOT Analysis, 2015
Table 57: Product Profile - Align Urethral Support System (C.R. Bard)
Table 58: Align Urethral Support System, SWOT Analysis, 2015
Table 59: Product Profile - Altis Single Incision Sling (Coloplast)
Table 60: Altis Single Incision Sling, SWOT Analysis, 2015
Table 61: Product Profile - Gynecare TVT (Ethicon)
Table 62: Gynecare TVT, SWOT Analysis, 2015
Table 63: Product Profile - MiniArc Single-Incision Sling (American Medical Systems)
Table 64: MiniArc Single-Incision Sling, SWOT Analysis, 2015
Table 65: Product Profile - Solyx (Boston Scientific)
Table 66: Solyx, SWOT Analysis, 2015
Table 67: Product Profile - Aegea Vapor System (Aegea Medical)
Table 68: Aegea Vapor System, SWOT Analysis, 2015
Table 69: Product Profile - Cryothermic Therapy (Channel Medsystems)
Table 70: Cryothermic Therapy, SWOT Analysis, 2015
Table 71: Product Profile - Biodegradable Bead
Table 72: Biodegradable Bead, SWOT Analysis, 2015
Table 73: Product Profile - FemBloc
Table 74: FemBloc, SWOT Analysis, 2015
Table 75: Product Profile - PTMC Mesh
Table 76: PTMC Mesh, SWOT Analysis, 2015
Table 77: Product Profile - sensiTVT
Table 78: sensiTVT, SWOT Analysis, 2015
Table 79: Company Profile - American Medical Systems
Table 80: American Medical Systems, SWOT Analysis, 2015
Table 81: Company Profile - AngioDynamics
Table 82: AngioDynamics, SWOT Analysis, 2015
Table 93: Company Profile - Bayer Healthcare
Table 84: Bayer Healthcare, SWOT Analysis, 2015
Table 85: Company Profile - Boston Scientific
Table 86: Boston Scientific, SWOT Analysis, 2015
Table 87: Company Profile - BTG
Table 88: BTG, SWOT Analysis, 2015
Table 89: Company Profile - Coloplast
Table 90: Coloplast, SWOT Analysis, 2015
Table 91: Company Profile - Cook Medical
Table 92: Cook Medical, SWOT Analysis, 2015
Table 93: Company Profile - CooperSurgical
Table 94: CooperSurgical, SWOT Analysis, 2015
Table 95: Company Profile - C.R. Bard
Table 96: C.R. Bard, SWOT Analysis, 2015
Table 97: Company Profile - Ethicon
Table 98: Ethicon, SWOT Analysis, 2015
Table 99: Company Profile - Femcare-Nikomed
Table 100: Femcare-Nikomed, SWOT Analysis, 2015
Table 101: Company Profile - Hologic
Table 102: Hologic, SWOT Analysis, 2015
Table 103: Company Profile - Karl Storz
Table 104: Karl Storz, SWOT Analysis, 2015
Table 105: Company Profile - Olympus
Table 106: Olympus, SWOT Analysis, 2015
Table 107: Company Profile - Richard Wolf
Table 108: Richard Wolf, SWOT Analysis, 2015
Table 109: Company Profile - Stryker
Table 110: Stryker, SWOT Analysis, 2015
Table 111: 5EU Women's Health Market Forecast ($m) by Market Segment, 2011-2021
Table 112: France Women's Health Market Forecast ($m) by Market Segment, 2011-2021
Table 113: France Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Table 114: France Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 115: France Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Table 116: France Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 117: France Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Table 118: Germany Women's Health Market Forecast ($m) by Market Segment, 2011-2021
Table 119: Germany Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Table 120: Germany Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 121: Germany Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Table 122: Germany Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 123: Germany Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Table 124: Italy Women's Health Market Forecast ($m) by Market Segment, 2011-2021
Table 125: Italy Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Table 126: Italy Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 127: Italy Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Table 128: Italy Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 129: Italy Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Table 130: Spain Women's Health Market Forecast ($m) by Market Segment, 2011-2021
Table 131: Spain Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Table 132: Spain Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 133: Spain Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Table 134: Spain Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 135: Spain Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Table 136: UK Women's Health Market Forecast ($m) by Market Segment, 2011-2021
Table 137: UK Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Table 138: UK Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 139: UK Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Table 140: UK Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Table 141: UK Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021

1.2 List of Figures
Figure 1: Percentage Breakdown of Urinary Incontinence, by Type
Figure 2: Percentage of Patients with Menorrhagia Receiving Treatment, by Type
Figure 3: Percentage of Patients with Urinary Incontinence Receiving Treatment, by Type
Figure 4: 5EU Procedure Volume Forecast, Endometrial Resection, 2011-2021
Figure 5: 5EU Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021
Figure 6: 5EU Procedure Volume Forecast, Female Sterilization, 2011-2021
Figure 7: 5EU Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021
Figure 8: 5EU Women's Health Market Forecast ($m) by Segment, 2011-2021
Figure 9: 5EU Women's Health Market Share by Market Segment, 2014 and 2021
Figure 10: France Women's Health Market Forecast ($m) by Segment, 2011-2021
Figure 11: France Women's Health Market Share by Market Segment, 2014 and 2021
Figure 12: France Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Figure 13: France Endometrial Ablation Market Share by Market Segment, 2014 and 2021
Figure 14: France Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
Figure 15: France TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
Figure 16: France Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Figure 17: France Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
Figure 18: France Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Figure 19: France Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
Figure 20: France Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Figure 21: Germany Women's Health Market Forecast ($m) by Segment, 2011-2021
Figure 22: Germany Women's Health Market Share by Market Segment, 2014 and 2021
Figure 23: Germany Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Figure 24: Germany Endometrial Ablation Market Share by Market Segment, 2014 and 2021
Figure 25: Germany Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
Figure 26: Germany TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
Figure 27: Germany Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Figure 28: Germany Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
Figure 29: Germany Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Figure 30: Germany Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
Figure 31: Germany Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Figure 32: Italy Women's Health Market Forecast ($m) by Segment, 2011-2021
Figure 33: Italy Women's Health Market Share by Market Segment, 2014 and 2021
Figure 34: Italy Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Figure 35: Italy Endometrial Ablation Market Share by Market Segment, 2014 and 2021
Figure 36: Italy Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
Figure 37: Italy TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
Figure 38: Italy Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Figure 39: Italy Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
Figure 40: Italy Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Figure 41: Italy Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Figure 42: Spain Women's Health Market Forecast ($m) by Segment, 2011-2021
Figure 43: Spain Women's Health Market Share by Market Segment, 2014 and 2021
Figure 44: Spain Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Figure 45: Spain Endometrial Ablation Market Share by Market Segment, 2014 and 2021
Figure 46: Spain Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
Figure 47: Spain TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
Figure 48: Spain Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Figure 49: Spain Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
Figure 50: Spain Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Figure 51: Spain Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
Figure 52: Spain Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Figure 53: UK Women's Health Market Forecast ($m) by Segment, 2011-2021
Figure 54: UK Women's Health Market Share by Market Segment, 2014 and 2021
Figure 55: UK Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
Figure 56: UK Endometrial Ablation Market Share by Market Segment, 2014 and 2021
Figure 57: UK Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
Figure 58: UK TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
Figure 59: UK Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
Figure 60: UK Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
Figure 61: UK Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
Figure 62: UK Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
Figure 63: UK Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
Figure 64: Primary Research Participants, by Country

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Sleep Aids: Technologies and Global Markets

Sleep Aids: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Analyze the current market dynamics and evaluate the effect of strategic factors such as technology-driven change and industry consolidation of sleep aids and technologies. - Review ...

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

This BCC Research report presents a comprehensive look at disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options. Forecast included from 2016 through 2021. ...

Flavored and Functional Water Market - Brazil Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Flavored and Functional Water Market - Brazil Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Brazil Flavored and Functional Water Market: Overview and Trends Transparency Market Research (TMR) offers 8-year forecast for the Brazil flavored and functional water market between 2016 and 2024. In ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.